Immunization for Ebola virus infection

Nature Medicine
L XuG J Nabel

Abstract

Infection by Ebola virus causes rapidly progressive, often fatal, symptoms of fever, hemorrhage and hypotension. Previous attempts to elicit protective immunity for this disease have not met with success. We report here that protection against the lethal effects of Ebola virus can be achieved in an animal model by immunizing with plasmids encoding viral proteins. We analyzed immune responses to the viral nucleoprotein (NP) and the secreted or transmembrane forms of the glycoprotein (sGP or GP) and their ability to protect against infection in a guinea pig infection model analogous to the human disease. Protection was achieved and correlated with antibody titer and antigen-specific T-cell responses to sGP or GP. Immunity to Ebola virus can therefore be developed through genetic vaccination and may facilitate efforts to limit the spread of this disease.

References

Apr 1, 1992·Journal of Clinical Microbiology·T G KsiazekC J Peters
Jan 1, 1992·Annual Review of Immunology·J L JorgensenM M Davis
Mar 23, 1990·Science·J A WolffP L Felgner
Feb 1, 1983·The Journal of Infectious Diseases·J B McCormickK M Johnson
Oct 1, 1995·Nature Medicine·W A Border, N A Noble
Jan 1, 1994·Cold Spring Harbor Symposia on Quantitative Biology·K OrthJ Sambrook
Sep 27, 1994·Proceedings of the National Academy of Sciences of the United States of America·E RazM A Yankauckas
Oct 11, 1994·Proceedings of the National Academy of Sciences of the United States of America·M SedegahS L Hoffman
May 15, 1993·Proceedings of the National Academy of Sciences of the United States of America·E RazD A Carson
Apr 16, 1996·Proceedings of the National Academy of Sciences of the United States of America·A SanchezS T Nichol
Aug 1, 1996·Nature Medicine·R E TasconD B Lowrie
Aug 6, 1996·Proceedings of the National Academy of Sciences of the United States of America·B DoeC M Walker
Oct 1, 1996·The Journal of Experimental Medicine·M CorrH Tighe
Jan 1, 1997·Immunology Today·R M Zinkernagel, P C Doherty
Apr 1, 1997·Gene Therapy·T OhnoG J Nabel
Aug 1, 1997·Nature Medicine·H AraiG J Nabel

❮ Previous
Next ❯

Citations

Oct 6, 2006·Springer Seminars in Immunopathology·Shan Lu
Jun 5, 2003·International Journal for Parasitology·Mary Kate Hart
Apr 30, 2003·Antiviral Research·Laura G BarrientosMichael R Boyd
Mar 5, 2003·Antiviral Research·Mike Bray
Apr 11, 2003·Virus Research·Jenny L Mellquist-RiemenschneiderConnie S Schmaljohn
Apr 11, 2003·Virus Research·Gary J Nabel
May 2, 2002·Vaccine·Gary J Nabel
May 9, 2002·Social Science & Medicine·Hélène Joffe, Georgina Haarhoff
Apr 13, 1999·Infectious Disease Clinics of North America·J R Haynes
May 26, 1999·Journal of Dermatological Science·A Morita, A Takashima
Oct 13, 2001·Trends in Microbiology·A Takada, Y Kawaoka
Dec 14, 1999·Microbes and Infection·H L Davis, M J McCluskie
Jul 16, 1999·Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology·E OperschallK Moelling
May 15, 2013·Molecular Therapy : the Journal of the American Society of Gene Therapy·Devon J ShedlockDavid B Weiner
Jan 14, 1998·Nature Medicine·T Folks
Jul 15, 2005·Nature Medicine·Sylvain Baize
Apr 2, 2005·Nature Reviews. Drug Discovery·James C BurnettSina Bavari
May 2, 2002·Clinical and Experimental Immunology·S BaizeE Mavoungou
Apr 16, 2005·Journal of Toxicology and Environmental Health. Part B, Critical Reviews·Jacquelyn J Bower, Xianglin Shi
May 25, 1999·Microbiology and Immunology·S SasakiK Okuda
Jul 10, 1999·Immunological Reviews·I H FrazerM Sharkey
Feb 13, 2001·Journal of Virology·A TakadaY Kawaoka
Dec 13, 2002·Journal of Virology·Zhi-yong YangGary J Nabel
Aug 28, 2003·Journal of Virology·Nancy SullivanGary J Nabel
Jun 29, 2004·Journal of Virology·Norman L LetvinGary J Nabel

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.